US Stock MarketDetailed Quotes

BCRX BioCryst Pharmaceuticals

Watchlist
  • 7.600
  • +0.110+1.47%
Close Nov 22 16:00 ET
  • 7.600
  • 0.0000.00%
Post 18:41 ET
1.57BMarket Cap-12459P/E (TTM)

BioCryst Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
141.44%8.25M
92.73%-1.37M
-12.99%-53.68M
41.22%-95.14M
62.61%-8.92M
38.67%-19.9M
32.22%-18.81M
38.93%-47.51M
-13.85%-161.85M
26.53%-23.85M
Net income from continuing operations
61.18%-14.03M
83.17%-12.67M
33.66%-35.38M
8.33%-226.54M
13.71%-61.73M
14.98%-36.15M
-27.98%-75.33M
28.12%-53.33M
-34.26%-247.12M
-302.39%-71.54M
Operating gains losses
----
----
----
--29.02M
--0
--0
----
----
----
----
Depreciation and amortization
-25.95%311K
-21.38%320K
-24.44%306K
15.17%1.66M
6.82%423K
7.97%420K
21.49%407K
27.76%405K
84.94%1.44M
131.58%396K
Other non cash items
-34.30%14.53M
-17.36%19.6M
-4.95%19.44M
-13.65%86.23M
-55.42%19.94M
20.22%22.11M
33.85%23.72M
7.63%20.45M
84.21%99.85M
151.81%44.73M
Change In working capital
43.62%-9.13M
-175.38%-18.3M
-75.44%-48.52M
45.03%-32.4M
253.94%18.1M
9.64%-16.2M
-301.58%-6.64M
15.04%-27.66M
-825.57%-58.95M
-179.66%-11.76M
-Change in receivables
-186.31%-3.32M
8.25%-8.25M
-290.14%-3.84M
71.61%-6.1M
61.14%-2.97M
358.96%3.84M
-69.73%-8.99M
128.65%2.02M
-3.14%-21.47M
-136.04%-7.64M
-Change in inventory
55.11%-1.52M
-17.71%739K
-1,031.30%-1.22M
88.33%-1.45M
178.19%907K
7.84%-3.39M
112.41%898K
137.01%131K
-41.70%-12.42M
45.72%-1.16M
-Change in prepaid assets
75.75%-1.47M
64.16%1.75M
143.42%1.11M
-164.03%-6.82M
148.93%710K
-7,273.17%-6.05M
-16.30%1.06M
-9.78%-2.55M
63.90%-2.58M
60.73%-1.45M
-Change in payables and accrued expense
69.45%-2.83M
-6,567.02%-12.53M
-63.70%-44.57M
24.84%-16.81M
1,964.17%19.87M
27.80%-9.26M
-101.30%-188K
-18.85%-27.23M
-151.31%-22.36M
-104.63%-1.07M
-Change in other working capital
----
----
----
-1,028.44%-1.23M
4.34%-419K
-1,041.26%-1.35M
413.51%570K
-146.67%-35K
-108.50%-109K
-153.03%-438K
Cash from discontinued investing activities
Operating cash flow
141.44%8.25M
92.73%-1.37M
-12.99%-53.68M
41.22%-95.14M
62.61%-8.92M
38.67%-19.9M
32.22%-18.81M
38.93%-47.51M
-13.85%-161.85M
26.53%-23.85M
Investing cash flow
Cash flow from continuing investing activities
-63.28%8.49M
87.13%-2.45M
126.85%28.76M
-2.54%-131.5M
-136.87%-28.47M
133.24%23.12M
80.46%-19.04M
-178.41%-107.11M
-911.43%-128.24M
794.38%77.22M
Net PPE purchase and sale
94.02%-59K
66.81%-155K
-46.88%-235K
-60.47%-2.17M
-5.32%-554K
-464.00%-987K
-91.39%-467K
60.59%-160K
43.35%-1.35M
52.53%-526K
Net investment purchase and sale
-64.54%8.55M
87.65%-2.29M
127.11%28.99M
-1.93%-129.33M
-135.91%-27.92M
134.75%24.11M
80.90%-18.57M
-180.96%-106.95M
-797.60%-126.89M
876.48%77.74M
Cash from discontinued investing activities
Investing cash flow
-63.28%8.49M
87.13%-2.45M
126.85%28.76M
-2.54%-131.5M
-136.87%-28.47M
133.24%23.12M
80.46%-19.04M
-178.41%-107.11M
-911.43%-128.24M
794.38%77.22M
Financing cash flow
Cash flow from continuing financing activities
4.00%1.27M
-106.70%-1.97M
-120.64%-1.05M
-63.10%32.49M
-175.57%-3.17M
-98.40%1.23M
19,870.07%29.36M
-30.98%5.08M
-75.53%88.03M
-98.79%4.2M
Net issuance payments of debt
---556K
-100.68%-402K
---390K
-20.10%58.38M
---1.17M
--0
--59.55M
--0
-75.13%73.07M
--0
Net common stock issuance
-45.45%6K
-94.17%12K
--11K
80.00%342K
--125K
--11K
--206K
--0
-99.62%190K
----
Proceeds from stock option exercised by employees
41.26%2.09M
-84.90%264K
-66.89%1.68M
-43.52%8.34M
-99.03%39K
-54.63%1.48M
1,089.12%1.75M
-30.98%5.08M
-6.16%14.77M
15.07%4.01M
Net other financing activities
0.38%-261K
---1.84M
---2.35M
---34.58M
---2.17M
---262K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
4.00%1.27M
-106.70%-1.97M
-120.64%-1.05M
-63.10%32.49M
-175.57%-3.17M
-98.40%1.23M
19,870.07%29.36M
-30.98%5.08M
-75.53%88.03M
-98.79%4.2M
Net cash flow
Beginning cash position
-45.73%80.21M
-45.00%86.13M
-63.28%112.45M
-39.69%306.24M
-38.60%152.49M
-46.07%147.79M
-60.74%156.6M
-39.69%306.24M
85.07%507.73M
21.80%248.34M
Current changes in cash
304.95%18.01M
31.91%-5.78M
82.63%-25.98M
3.91%-194.15M
-170.47%-40.56M
117.33%4.45M
93.21%-8.49M
-37.30%-149.54M
-186.60%-202.06M
-81.05%57.57M
Effect of exchange rate changes
236.36%851K
54.89%-143K
-254.17%-340K
-36.04%362K
57.70%522K
1,907.14%253K
-251.67%-317K
-340.00%-96K
697.18%566K
16,450.00%331K
End cash Position
-35.04%99.06M
-45.73%80.21M
-45.00%86.13M
-63.28%112.45M
-63.28%112.45M
-38.60%152.49M
-46.07%147.79M
-60.74%156.6M
-39.69%306.24M
-39.69%306.24M
Free cash flow
139.20%8.19M
92.10%-1.52M
-13.10%-53.92M
40.37%-97.31M
61.14%-9.47M
35.98%-20.88M
31.14%-19.28M
39.04%-47.67M
-12.91%-163.2M
27.38%-24.38M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 141.44%8.25M92.73%-1.37M-12.99%-53.68M41.22%-95.14M62.61%-8.92M38.67%-19.9M32.22%-18.81M38.93%-47.51M-13.85%-161.85M26.53%-23.85M
Net income from continuing operations 61.18%-14.03M83.17%-12.67M33.66%-35.38M8.33%-226.54M13.71%-61.73M14.98%-36.15M-27.98%-75.33M28.12%-53.33M-34.26%-247.12M-302.39%-71.54M
Operating gains losses --------------29.02M--0--0----------------
Depreciation and amortization -25.95%311K-21.38%320K-24.44%306K15.17%1.66M6.82%423K7.97%420K21.49%407K27.76%405K84.94%1.44M131.58%396K
Other non cash items -34.30%14.53M-17.36%19.6M-4.95%19.44M-13.65%86.23M-55.42%19.94M20.22%22.11M33.85%23.72M7.63%20.45M84.21%99.85M151.81%44.73M
Change In working capital 43.62%-9.13M-175.38%-18.3M-75.44%-48.52M45.03%-32.4M253.94%18.1M9.64%-16.2M-301.58%-6.64M15.04%-27.66M-825.57%-58.95M-179.66%-11.76M
-Change in receivables -186.31%-3.32M8.25%-8.25M-290.14%-3.84M71.61%-6.1M61.14%-2.97M358.96%3.84M-69.73%-8.99M128.65%2.02M-3.14%-21.47M-136.04%-7.64M
-Change in inventory 55.11%-1.52M-17.71%739K-1,031.30%-1.22M88.33%-1.45M178.19%907K7.84%-3.39M112.41%898K137.01%131K-41.70%-12.42M45.72%-1.16M
-Change in prepaid assets 75.75%-1.47M64.16%1.75M143.42%1.11M-164.03%-6.82M148.93%710K-7,273.17%-6.05M-16.30%1.06M-9.78%-2.55M63.90%-2.58M60.73%-1.45M
-Change in payables and accrued expense 69.45%-2.83M-6,567.02%-12.53M-63.70%-44.57M24.84%-16.81M1,964.17%19.87M27.80%-9.26M-101.30%-188K-18.85%-27.23M-151.31%-22.36M-104.63%-1.07M
-Change in other working capital -------------1,028.44%-1.23M4.34%-419K-1,041.26%-1.35M413.51%570K-146.67%-35K-108.50%-109K-153.03%-438K
Cash from discontinued investing activities
Operating cash flow 141.44%8.25M92.73%-1.37M-12.99%-53.68M41.22%-95.14M62.61%-8.92M38.67%-19.9M32.22%-18.81M38.93%-47.51M-13.85%-161.85M26.53%-23.85M
Investing cash flow
Cash flow from continuing investing activities -63.28%8.49M87.13%-2.45M126.85%28.76M-2.54%-131.5M-136.87%-28.47M133.24%23.12M80.46%-19.04M-178.41%-107.11M-911.43%-128.24M794.38%77.22M
Net PPE purchase and sale 94.02%-59K66.81%-155K-46.88%-235K-60.47%-2.17M-5.32%-554K-464.00%-987K-91.39%-467K60.59%-160K43.35%-1.35M52.53%-526K
Net investment purchase and sale -64.54%8.55M87.65%-2.29M127.11%28.99M-1.93%-129.33M-135.91%-27.92M134.75%24.11M80.90%-18.57M-180.96%-106.95M-797.60%-126.89M876.48%77.74M
Cash from discontinued investing activities
Investing cash flow -63.28%8.49M87.13%-2.45M126.85%28.76M-2.54%-131.5M-136.87%-28.47M133.24%23.12M80.46%-19.04M-178.41%-107.11M-911.43%-128.24M794.38%77.22M
Financing cash flow
Cash flow from continuing financing activities 4.00%1.27M-106.70%-1.97M-120.64%-1.05M-63.10%32.49M-175.57%-3.17M-98.40%1.23M19,870.07%29.36M-30.98%5.08M-75.53%88.03M-98.79%4.2M
Net issuance payments of debt ---556K-100.68%-402K---390K-20.10%58.38M---1.17M--0--59.55M--0-75.13%73.07M--0
Net common stock issuance -45.45%6K-94.17%12K--11K80.00%342K--125K--11K--206K--0-99.62%190K----
Proceeds from stock option exercised by employees 41.26%2.09M-84.90%264K-66.89%1.68M-43.52%8.34M-99.03%39K-54.63%1.48M1,089.12%1.75M-30.98%5.08M-6.16%14.77M15.07%4.01M
Net other financing activities 0.38%-261K---1.84M---2.35M---34.58M---2.17M---262K----------------
Cash from discontinued financing activities
Financing cash flow 4.00%1.27M-106.70%-1.97M-120.64%-1.05M-63.10%32.49M-175.57%-3.17M-98.40%1.23M19,870.07%29.36M-30.98%5.08M-75.53%88.03M-98.79%4.2M
Net cash flow
Beginning cash position -45.73%80.21M-45.00%86.13M-63.28%112.45M-39.69%306.24M-38.60%152.49M-46.07%147.79M-60.74%156.6M-39.69%306.24M85.07%507.73M21.80%248.34M
Current changes in cash 304.95%18.01M31.91%-5.78M82.63%-25.98M3.91%-194.15M-170.47%-40.56M117.33%4.45M93.21%-8.49M-37.30%-149.54M-186.60%-202.06M-81.05%57.57M
Effect of exchange rate changes 236.36%851K54.89%-143K-254.17%-340K-36.04%362K57.70%522K1,907.14%253K-251.67%-317K-340.00%-96K697.18%566K16,450.00%331K
End cash Position -35.04%99.06M-45.73%80.21M-45.00%86.13M-63.28%112.45M-63.28%112.45M-38.60%152.49M-46.07%147.79M-60.74%156.6M-39.69%306.24M-39.69%306.24M
Free cash flow 139.20%8.19M92.10%-1.52M-13.10%-53.92M40.37%-97.31M61.14%-9.47M35.98%-20.88M31.14%-19.28M39.04%-47.67M-12.91%-163.2M27.38%-24.38M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data